شنبه 1 دی 1403
[Archive]
دوره 29، شماره 134 - ( 2-1400 )
جلد 29 شماره 134 صفحات 175-167 |
برگشت به فهرست نسخه ها
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Parsamanesh N, Ahmadi Shadmehri A, Zarifi S, Miri-Moghaddam E. Identification of the Peroxisomal Biogenesis Factor 1 Gene Point Mutation in an Iranian Family with Zellweger Syndrome (ZS). J Adv Med Biomed Res 2021; 29 (134) :167-175
URL: http://journal.zums.ac.ir/article-1-6103-fa.html
URL: http://journal.zums.ac.ir/article-1-6103-fa.html
Identification of the Peroxisomal Biogenesis Factor 1 Gene Point Mutation in an Iranian Family with Zellweger Syndrome (ZS). Journal of Advances in Medical and Biomedical Research. 1400; 29 (134) :167-175
چکیده: (136538 مشاهده)
Background & Objective: Peroxisome biogenesis disorders (PBDs) are a group of diseases with peroxisomal dysfunction. Wide range of symptoms are associated with the disease which are due to mutations in the PEX genes. The PEX1 mutation occurs in Zellweger syndrome (ZS), a severe autosomal recessive condition with hypotonia, intellectual disability, and hepatic enlargement. The present study determined the molecular aspects of ZS in a family in South Khorasan Province, Iran.
Materials & Methods: Whole-exome sequencing (WES) was performed, clinical history was taken, and the family pedigree was drawn. Subsequently, Sanger sequencing was performed for unique primers. Afterwards, in terms of ZS phenotype, in silico studies were done to examine the changes that occurred in the protein structure.
Results: The PEX1 (NC_000007.14) mutation was detected at location Chr7q21.2. This chromosomal location was anticipated as the disorder-causing variant. GGT (Glycine) changes to GAT (Aspartate) in codon 843 were confirmed by Sanger sequencing. Examination results of the mentioned family revealed a missense mutation in the PEX1.
Conclusion: In conclusion, our study indicated a mutation in the PEX1 in the affected family. This mutation is a missense variant at codon 843 in ZS patients. It has an autosomal recessive inheritance pattern. This mutation may be widespread among Iranian population with ZS and can be used for a more desirable personalized medicine.
نوع مطالعه: مقاله پژوهشی |
موضوع مقاله:
Medical Biology
دریافت: 1399/4/15 | پذیرش: 1399/6/25 | انتشار: 1399/10/10
دریافت: 1399/4/15 | پذیرش: 1399/6/25 | انتشار: 1399/10/10
فهرست منابع
1. Schlüter A, Fourcade S, Domènech-Estévez E, et al. PeroxisomeDB: a database for the peroxisomal proteome, functional genomics and disease. Nucleic Acids Res. 2006;35(suppl_1):D815-D22. [DOI:10.1093/nar/gkl935]
2. Wanders RJ, Waterham HR. Biochemistry of mammalian peroxisomes revisited. Annu Rev Biochem. 2006;75:295-332. [DOI:10.1146/annurev.biochem.74.082803.133329]
3. Wanders R, Waterham H. Peroxisomal disorders I: biochemistry and genetics of peroxisome biogenesis disorders. Clin Genet. 2005;67(2):107-33. [DOI:10.1111/j.1399-0004.2004.00329.x]
4. Bacino CA, Chao YH, Seto E, et al. A homozygous mutation in PEX16 identified by whole-exome sequencing ending a diagnostic odyssey. Molec Genet Metab Report. 2015;5:15-8. [DOI:10.1016/j.ymgmr.2015.09.001]
5. Elumalai V, Pasrija D. Zellweger Syndrome. StatPearls. Treasure Island (FL): StatPearls Publishing
6. Copyright © 2020, StatPearls Publishing LLC.; 2020.
7. Gould SJ, Valle D. Peroxisome biogenesis disorders: genetics and cell biology. Trend Genet. 2000;16(8):340-5. [DOI:10.1016/S0168-9525(00)02056-4]
8. Krause C, Rosewich H, Thanos M, Gärtner J. Identification of novel mutations in PEX2, PEX6, PEX10, PEX12, and PEX13 in Zellweger spectrum patients. Human Mutat. 2006;27(11):1157-. [DOI:10.1002/humu.9462]
9. Faust P, Banka D, Siriratsivawong R, Ng V, Wikander T. Peroxisome biogenesis disorders: the role of peroxisomes and metabolic dysfunction in developing brain. J Inherit Metab Disease. 2005;28(3):369-83. [DOI:10.1007/s10545-005-7059-y]
10. Klouwer FC, Berendse K, Ferdinandusse S, Wanders RJ, Engelen M. Zellweger spectrum disorders: clinical overview and management approach. Orphanet J Rare Disease. 2015;10(1):151. [DOI:10.1186/s13023-015-0368-9]
11. Gonzaga-Jauregui C, Lupski JR, Gibbs RA. Human genome sequencing in health and disease. Ann Rev Med. 2012;63:35-61. [DOI:10.1146/annurev-med-051010-162644]
12. Li Y, Shan Z, Teng W, et al. Abnormalities of maternal thyroid function during pregnancy affect neuropsychological development of their children at 25-30 months. Clin Endocrinol. 2010;72(6):825-9. [DOI:10.1111/j.1365-2265.2009.03743.x]
13. Yang Y, Muzny DM, Reid JG, et al. Clinical whole-exome sequencing for the diagnosis of mendelian disorders. New Engl J Med. 2013;369(16):1502-11. [DOI:10.1056/NEJMoa1306555]
14. Parsamanesh N, Safarpour H, Etesam S, Shadmehri AA, Miri-Moghaddam E. Identification and in silico characterization of a novel point mutation within the phosphatidylinositol glycan anchor biosynthesis class G gene in an Iranian family with intellectual disability. J Molec Neurosci. 2019;69(4):538-45. [DOI:10.1007/s12031-019-01376-y]
15. Moossavi M, Parsamanesh N, Mohammadoo‐Khorasani M, et al. Positive correlation between vitamin D receptor gene FokI polymorphism and colorectal cancer susceptibility in South‐Khorasan of Iran. J Cell Biochem. 2018;119(10):8190-4. [DOI:10.1002/jcb.26826]
16. Naseri M, Sebzari A, Haghighi F, Hajipoor F, Emadian Razavi F. Frequency of K-RAS and N-RAS gene mutations in colorectal cancers in southeastern Iran. Asian Pacific J Cancer Prevent. 2016;17(9):4511-5.
17. Parsamanesh N, Moossavi M, Tavakkoli T, et al. Positive correlation between vitamin D receptor gene TaqI variant and gastric cancer predisposition in a sample of Iranian population. J Cell Physiol. 2019;234(9):15044-7. [DOI:10.1002/jcp.28145]
18. Waterham HR, Ferdinandusse S, Wanders RJ. Human disorders of peroxisome metabolism and biogenesis. Biochimica Et Biophysica Acta (BBA)-Molecular Cell Research. 2016;1863(5):922-33. [DOI:10.1016/j.bbamcr.2015.11.015]
19. Farr RL, Lismont C, Terlecky SR, Fransen M. Peroxisome biogenesis in mammalian cells: The impact of genes and environment. Biochimica et Biophysica Acta (BBA)-Molecular Cell Research. 2016;1863(5):1049-60. [DOI:10.1016/j.bbamcr.2015.08.011]
20. Fu X, Sun X, Zhang L, et al. Tuberous sclerosis complex-mediated mTORC1 overactivation promotes age-related hearing loss. J Clin Investigat. 2018;128(11):4938-55. [DOI:10.1172/JCI98058]
21. Preuss N, Brosius U, Biermanns M, Muntau AC, Conzelmann E, Gärtner J. PEX1 mutations in complementation group 1 of Zellweger spectrum patients correlate with severity of disease. Pediatr Res. 2002;51(6):706. [DOI:10.1203/00006450-200206000-00008]
22. Reuber BE, Germain-Lee E, Collins CS, et al. Mutations in PEX1 are the most common cause of peroxisome biogenesis disorders. Nature Genet. 1997;17(4):445. [DOI:10.1038/ng1297-445]
23. Ge MM, Hu L, Li Z, et al. Novel compound heterozygous mutations in the PEX1 gene in two Chinese newborns with Zellweger syndrome based on whole exome sequencing. Clinica Chimica Acta. 2017;470:24-8. [DOI:10.1016/j.cca.2017.04.016]
24. Yu HL, Shen Y, Sun YM, Zhang Y. Two novel mutations of PEX6 in one Chinese Zellweger spectrum disorder and their clinical characteristics. Ann Translation Med. 2019;7(16):368. [DOI:10.21037/atm.2019.06.42]
25. Barillari MR, Karali M, Di Iorio V, et al. Mild form of Zellweger Spectrum disorders (ZSD) due to variants in PEX1: Detailed clinical investigation in a 9-years-old female. Molec Genet Metab Report. 2020;24:100615. [DOI:10.1016/j.ymgmr.2020.100615]
26. Bousfiha A, Bakhchane A, Charoute H, et al. A novel PEX1 mutation in a Moroccan family with Zellweger spectrum disorders. Human Genome Variat. 2017;4:17009. [DOI:10.1038/hgv.2017.9]
27. Zou Q, Zheng J, Zhang R, Fang Y, Cai C. A case of intellectual disability reveals a novel mutation in IQSEC2 gene by whole exome sequencing. Psychiatr Genetics. 2019;29(6):243-7. [DOI:10.1097/YPG.0000000000000232]
28. Wang W, Corominas R, Lin GN. De novo mutations from whole exome sequencing in neurodevelopmental and psychiatric disorders: from discovery to application. Front Genet. 2019;10:258. [DOI:10.3389/fgene.2019.00258]
29. Tamura S, Okumoto K, Toyama R, et al. Human PEX1 cloned by functional complementation on a CHO cell mutant is responsible for peroxisome-deficient Zellweger syndrome of complementation group I. Proceedings of the National Academy of Sciences of the United States of America. 1998;95(8):4350-5. [DOI:10.1073/pnas.95.8.4350]
30. https://www.ncbi.nlm.nih.gov/clinvar/variation/217431/#clinical-assertions.
31. https://www.ncbi.nlm.nih.gov/clinvar/variation/488572/.
32. https://www.ncbi.nlm.nih.gov/clinvar/variation/371698/.
33. https://www.ncbi.nlm.nih.gov/clinvar/variation/167443/.
34. Yang Y, Muzny DM, Xia F, et al. Molecular findings among patients referred for clinical whole-exome sequencing. JAMA. 2014;312(18):1870-9. [DOI:10.1001/jama.2014.14601]
35. Smith CE, Poulter JA. Spectrum of PEX1 and PEX6 variants in Heimler syndrome. 2016;24(11):1565-71. [DOI:10.1038/ejhg.2016.62]
36. Ebberink MS, Mooijer PA, Gootjes J, Koster J, Wanders RJ, Waterham HR. Genetic classification and mutational spectrum of more than 600 patients with a Zellweger syndrome spectrum disorder. Hum Mutat. 2011;32(1):59-69. [DOI:10.1002/humu.21388]
37. https://www.ncbi.nlm.nih.gov/clinvar/variation/371696/.
38. Walter C, Gootjes J, Mooijer PA, et al. Disorders of peroxisome biogenesis due to mutations in PEX1: phenotypes and PEX1 protein levels. Am J Human Genet. 2001;69(1):35-48. [DOI:10.1086/321265]
39. Rosewich H, Ohlenbusch A, Gartner J. Genetic and clinical aspects of Zellweger spectrum patients with PEX1 mutations. J Med Genet. 2005;42(9):e58. [DOI:10.1136/jmg.2005.033324]
| بازنشر اطلاعات | |
 |
این مقاله تحت شرایط Creative Commons Attribution-NonCommercial 4.0 International License قابل بازنشر است. |
